Self‐Reported Barriers to Exercise and Factors Impacting Participation in Exercise in Patients with Parkinson's Disease

بواسطة Prakash, Prarthana, Scott, Thomas F., Baser, Susan M., Leichliter, Timothy, Schramke, Carol J.
الحاوية / القاعدة Mov Disord Clin Pract (2021)

Matching comparisons of therapeutic efficacy suggest better clinical outcomes for patients treated with peginterferon beta-1a than with glatiramer acetate

بواسطة Scott, Thomas F., Su, Ray, Xiong, Kuangnan, Altincatal, Arman, Castrillo-Viguera, Carmen, Naylor, Maria L.
الحاوية / القاعدة Ther Adv Neurol Disord (2021)

Outcomes in a Modern Cohort of Treated Patients with Multiple Sclerosis from Diagnosis Up to 15 Years

بواسطة Scott, Thomas F., Desai, Troy, Hackett, Chris, Gettings, Edward J., Hentosz, Teresa, Elmalik, Wisam, Schramke, Carol J.
الحاوية / القاعدة Int J MS Care (2020)

Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2(+ )and decreased levels of IL23R(+ )CD4(+ )T - Lymphocytes in multiple sc...

بواسطة Kress-Bennett, Jennifer M, Ehrlich, Garth D, Bruno, Ashley, Post, J Christopher, Hu, Fen Z, Scott, Thomas F
منشور في 2011

Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis

بواسطة Scott, Thomas F, Kieseier, Bernd C, Newsome, Scott D, Arnold, Douglas L, You, Xiaojun, Hung, Serena, Sperling, Bjoern
الحاوية / القاعدة Mult Scler J Exp Transl Clin (2016)

Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN

بواسطة Newsome, Scott D., Scott, Thomas F., Arnold, Douglas L., Nelles, Gereon, Hung, Serena, Cui, Yue, Shang, Shulian, Naylor, Maria L., Kremenchutzky, Marcelo
الحاوية / القاعدة Ther Adv Neurol Disord (2018)